Trace Genomics, Inc. — Form D
Trace Genomics, Inc. of Redwood City, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-06-01. The offering totals $17.0M, of which $14.1M was reported sold. Industry: Other.
Offering
- Filed: 2020-06-01
- Form: D
- Accession: 0001741875-20-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $17.0M
- Amount sold: $14.1M
- Remaining: $2.9M
- Investors: 7
- Date of first sale: 2020-05-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-368042
Issuer
- Name: Trace Genomics, Inc.
- CIK: 0001741875
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 303 Twin Dolphin Drive, Redwood City, CA, 94065
- Phone: (844) 672-5749
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| WILLIAM BUCKNER | Director | RALEIGH, NC |
| Cristina Rohr | Director | Arlington, VA |
| VEERY MAXWELL | Director | SAN FRANCISCO, CA |
| Joe Pianelli | Director | Redwood City, CA |
| Michael Toelle | Director | Redwood City, CA |
| Daniel Vradenburg | Director | Redwood City, CA |
| Daniel Vradenburg | Executive Officer | Redwood City, CA |
| Poornima Parameswaran | Director | Burlingame, CA |
| Poornima Parameswaran | Executive Officer | Burlingame, CA |
| Diane Wu | Director | Burlingame, CA |
| Diane Wu | Executive Officer | Burlingame, CA |
Other filings by this issuer (4)
More